Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
CC transcript
Pernix Sleep, Inc. (SOMX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/29/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/13/2013 RW Form RW - Registration Withdrawal Request
03/13/2013 EFFECT Form EFFECT - Notice of Effectiveness
03/12/2013 8-K Quarterly results
03/11/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
03/08/2013 S-3/A Form S-3 - Registration statement under Securities Act of 1933 [amend]
03/08/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/06/2013 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
02/14/2013 SC 13G/A ISZO CAPITAL LP reports a 4.2% stake in Somaxon Pharmaceuticals, Inc.
02/07/2013 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
02/05/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
02/04/2013 SC 13G MMCAP International Inc. SPC reports a 6.3% stake in SOMAXON PHARMACEUTICALS, INC.
02/01/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
01/18/2013 SC 13G RTW INVESTMENTS, LLC reports a 5.4% stake in SOMAXON PHARMACEUTICALS, INC.
12/21/2012 SC 13G ISZO CAPITAL LP reports a 8.9% stake in Somaxon Pharmaceuticals, Inc.
12/21/2012 8-K Other Events
12/21/2012 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
12/14/2012 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/11/2012 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger by and among Pernix Therapeutics Holdings, Inc., Pernix Acquisition Corp. I and Somaxon Pharmaceuticals, Inc",
"Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc."
12/11/2012 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/01/2012 10-Q Quarterly Report for the period ended September 30, 2012
10/31/2012 8-K Quarterly results
Docs: "SOMAXON PHARMACEUTICALS REPORTS THIRD QUARTER 2012 FINANCIAL RESULTS"
10/16/2012 CT ORDER Form CT ORDER - Confidential treatment order
10/11/2012 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Somaxon Pharmaceuticals, Inc., effective 5:00 p.m. Pacific Time, October 11, 2012",
"SOMAXON PHARMACEUTICALS APPROVES 1-FOR-8 REVERSE STOCK SPLIT AND DECREASE IN THE NUMBER OF AUTHORIZED SHARES OF ITS COMMON STOCK TO 25,000,000 SHARES"
09/14/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment No. 3 to Manufacturing Services Agreement dated September 12, 2012, between Somaxon Pharmaceuticals, Inc. and Patheon Pharmaceuticals Inc"
08/29/2012 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financi...
Docs: "Office Lease Agreement between Somaxon Pharmaceuticals, Inc. and SB Corporate Centre III-IV, LLC",
"Lease Termination Agreement between Somaxon Pharmaceuticals, Inc. and TREA Pacific Plaza, LLC"
08/27/2012 DEF 14A Form DEF 14A - Other definitive proxy statements
08/27/2012 GN Somaxon Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
08/22/2012 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/21/2012 PRE 14A Form PRE 14A - Other preliminary proxy statements
08/17/2012 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/08/2012 10-Q Quarterly Report for the period ended June 30, 2012
08/07/2012 8-K Quarterly results
Docs: "SOMAXON PHARMACEUTICALS REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS"
08/06/2012 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy